default author photo

Nacho Aguilo

University of Zaragoza

Gran Via 2

Zaragoza, 50005

Spain

  • University of Zaragoza

SCHOLARLY PAPERS

2

DOWNLOADS

240

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Live-Attenuated M. Tuberculosis Vaccine, MTBVAC, in Adults with or Without M. Tuberculosis Sensitization: A Phase 1b/2a Randomized, Controlled, Double-Blind, Dose-Escalation Trial

Number of pages: 29 Posted: 02 Oct 2023
Angelique Kany Kany Luabeya, Virginie Rozot, Claire Imbratta, Frances Ratangee, Justin Shenje, Michèle Tameris, Simon C. Mendelsohn, Hennie Geldenhuys, Michelle Fisher, Munyaradzi Musvosvi, Humphrey Mulenga, Nicole Bilek, Simbarashe Mabwe, Ingrid Murillo Jelsbak, Esteban Rodríguez, Eugenia Puentes, Juana Doce, Nacho Aguilo, Carlos Martin, Cadwill Pillay, Dereck Tait, Lewis Schrager, Marisa Russell, Kathryn Rutkowski, Devin Hunt, Thomas J. Scriba and Mark Hatherill
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Stellenbosch University, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads 124 (580,653)

Abstract:

Loading...

tuberculosis, MTBVAC, Vaccine, safety, immunogenicity

2.

Safety, Reactogenicity, and Immunogenicity of Mtbvac in Infants: A Phase 2a Randomized, Double-Blind, Dose-Defining Trial in a Tb Endemic Setting

Number of pages: 22 Posted: 31 May 2024
Michèle Tameris, Virginie Rozot, Claire Imbratta, Hennie Geldenhuys, Simon C. Mendelsohn, Angelique Kany Kany Luabeya, Justin Shenje, Nicolette Tredooux, Michelle Fisher, Humphrey Mulenga, Nicole Bilek, Carly Young, Ashley Veldsman, Natasja Botes, Jelle Thole, Bernard Fritzell, Rajat Mukherjee, Ingrid Murillo Jelsbak, Esteban Rodrigues, Eugenia Puentes, Juana Doce, Dessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, Carlos Martin, Thomas J. Scriba and Mark Hatherill
University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, Biofabri, Biofabri, Mukherjee Consultants, Biofabri, Biofabri, Biofabri, Biofabri, University of Zaragoza, University of Zaragoza, University of Zaragoza, University of Zaragoza, University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative and University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative
Downloads 116 (613,149)

Abstract:

Loading...

tuberculosis, newborns, vaccine, BCG, MTBVAC